Research programme: s-salmeterol - SepracorAlternative Names: (S)-salmeterol; S-salmeterol
Latest Information Update: 11 Jul 2007
At a glance
- Originator Sepracor
- Class Antiasthmatics; Antibronchitics; Bronchodilators; Ethanolamines; Phenethylamines; Small molecules
- Mechanism of Action Beta 2 adrenergic receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 18 Apr 2001 New profile
- 31 Dec 1999 Preclinical development for Asthma in USA (Inhalation)